Skip to content

13F-HR filed by Velan Capital Investment Management LP

Velan Capital Investment Management LP filed this 13F-HR for the quarter ended 2026-09-30, accepted by EDGAR 2026-11-16 11:46:00 UTC, with 43 holding rows worth $104,739,052.

Accession
0001848809-26-000006
Filed
2026-11-16
Accepted by EDGAR
Ingested
Source
EDGAR live feed

Original filing

13F report for Q3 2026

A holdings report, 44 entries on the cover page, a total value of $104,739,052 stated on the cover page (in dollars after the unit check, H1), rows summing to $104,739,052 with VALUE read as dollars as filed, 13F file number 028-21996. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
PRAXIS PRECISION MEDICINES I74006W207COM NEW76,600$22,308,218dollars as filed
IMMIX BIOPHARMA INC45258H106COMMON STOCK1,085,000$11,289,425dollars as filed
PROTARA THERAPEUTICS INC74365U107COM STK2,844,652$8,676,189dollars as filed
SUTRO BIOPHARMA INC869367201COMMON STOCK510,038$8,216,712dollars as filed
ABIVAX SA-00370M103SPONSORED ADS65,630$6,498,683dollars as filed
MAPLIGHT THERAPEUTICS INC56565P103COMMON STOCK624,703$6,365,724dollars as filed
ANTERIS TECHNOLOGIES GLOBAL03675P102COMMON STOCK700,000$5,439,000dollars as filed
EDESA BIOTECH INC27966L306COM NEW1,282,045$5,397,409dollars as filed
AVALO THERAPEUTICS INC05338F306COMMON STOCK324,452$4,973,849dollars as filed
XENCOR INC98401F105COMMON STOCK175,000$4,366,250dollars as filed
EVOMMUNE INC30054Y107COMMON STOCK456,255$3,768,666dollars as filed
EUPRAXIA PHARMACEUTICALS INC29842P105COM 298736 AL 3 EURONET WORLDWIDE INC NOTE 0.750% 3/1352,000$3,203,200dollars as filed
HERON THERAPEUTICS INC427746102COM8,753,290$2,744,156dollars as filed
EDGEWISE THERAPEUTICS INC28036F105COM34,250$1,390,550dollars as filed
REIN THERAPEUTICS INC00887A204COM NEW1,700,000$1,366,800dollars as filed
NASUS PHARMA LTDM7071P109ORD SHS359,390$1,326,149dollars as filed
Q32 BIO INC746964105Common Stock120,000$992,400dollars as filed
INSPIREMD INC45779A846COM924,680$617,501dollars as filed
PROTAGONIST THERAPEUTICS74366E102COM3,700$521,293dollars as filed
AARDVARK THERAPEUTICS INC002942100COM85,868$452,524dollars as filed
NURIX THERAPEUTICS INC67080M103COMMON STOCK16,000$379,360dollars as filed
CYTOMX THERAPEUTICS INC23284F105COMMON STOCK120,000$326,400dollars as filed
OVID THERAPEUTICS INC690469101COMMON STOCK130,000$323,700dollars as filed
MINERALYS THERAPEUTICS INC603170101COM11,000$276,430dollars as filed
REPLIMUNE GROUP INC76029N106COMMON STOCK20,000$264,800dollars as filed
PRECISION BIOSCIENCES INC74019P207COM NEW40,000$250,400dollars as filed
ZAI LAB LTD ADR98887Q104ADR9,000$237,060dollars as filed
C4 THERAPEUTICS INC12529R107COM STK70,000$233,100dollars as filed
MACROGENICS INC556099109COM60,000$231,600dollars as filed
IMMUNOME INC45257U108COM10,000$215,100dollars as filed
AN2 THERAPEUTICS INC037326105COM40,000$212,800dollars as filed
VIRIDIAN THERAPEUTICS INC92790C104COM10,000$205,900dollars as filed
CORBUS PHARMACEUTICALS21833P301COM NEW30,000$204,600dollars as filed
ENANTA PHARMACEUTICALS INC29251M106COM15,000$197,700dollars as filed
SCYNEXIS INC811292309COM40,000$197,600dollars as filed
ARTIVA BIOTHERAPEUTICS INC04317A107COM25,000$178,000dollars as filed
ROCKET PHARMACEUTICALS INC77313F106COM60,000$157,800dollars as filed
LYELL IMMUNOPHARMA INC COM NEW55083R203Stock15,000$146,850dollars as filed
JADE BIOSCIENCES INC008064206COM NEW10,000$140,500dollars as filed
NEUMORA THERAPEUTICS INC.640979100COM230,000$137,126dollars as filed
TENAX THERAPEUTICS INC88032L605COM NEW68,700$129,843dollars as filedcall
LARIMAR THERAPEUTICS INC517125100COM33,000$105,435dollars as filed
KALARIS THERAPEUTICS INC482929106COM25,000$72,250dollars as filed

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001848809-26-000006this filing2026-11-16